eureKARE joins DNA Data Storage Alliance
eureKARE Joins the DNA Data Storage Alliance
- eureKARE join the DNA Data Storage Alliance Foundationby Illuminated, Inc., Microsoft, Twist Biosciences company and western digital
- Member collaborate at to construct awareness and promote the adoption of DNA Dat sget carried away efficient and ecological solution to explosive data growth
LuxemburgBelgium, and Paris, France- 26 January 2022: eureKARE (“the Company”), a pioneering company focused on funding and building next-generation biotechnology companies in the disruptive fields of synthetic biology and the microbiome, today announces that it has joined DNA Data Storage Alliance.
Formed in October 2020 by Illumina, Microsoft, Twist Bioscience and Western Digital, the DNA Data Storage Alliance is the world’s first and largest alliance of industry and academic organizations in the field of DNA data storage. The Alliance shares the mission to create and promote an interoperable storage ecosystem based on DNA as a data storage medium. This is done through public education, awareness and the publication of white papers describing the technology and its potential uses. Membership is made up of a wide range of stakeholders, combining a range of expertise, all essential to DNA data storage.
Christine Thompson, commercial director of eureKARE, remarkD: “We are delighted to join the DNA Data Storage Alliance. It is clear to us that digital data storage is a major challenge for our generation and one that we hope to address by investing in DNA data storage approaches. DNA is a wonderful ecological solution to this problem due to its extremely dense nature. Market demand for a durable and inexpensive approach such as DNA data storage is expected to grow exponentially over the next few years and this technology truly has the potential to revolutionize our lives. Working together to create the architecture needed to read, store, and write data is an essential first step.
eureKARE is an active player in the DNA data storage space and aims to invest in opportunities that address the challenge of the explosive growth of digital data through the use of DNA data storage to protect invaluable digital information. eureKARE has a direct understanding of the importance of archiving and backing up data, due to mining large datasets for the company’s own AI-driven tool, eureK[AI].
Storing and accessing data is becoming an increasingly recognized challenge as massive amounts of digital data continue to be produced. DNA offers properties that provide an ideal solution to this problem; it naturally writes and stores data accessible centuries later with great stability. Additionally, the compact size and low power requirements of DNA are also attractive advantages, as today’s data storage needs require significant amounts of power and space.
– To finish –
eureKARE is a unique investment company dedicated to developing next-generation biotechnology companies in the cutting-edge areas of synthetic biology and the microbiome. eureKARE has a two-step investment approach to creating long-term value. The Company supports translational research by creating and financing new companies resulting from European innovation with high added value through its biotech start-up studios eureKABIOME (Microbiome) and eureKASYNBIO (Synthetic biology). The Company also intends to invest in more mature biotechnology companies and will systematically offer to offer liquidity to early investors, thus meeting a critical need in the European biotechnology field. Guided by its influential founder, Alexandre Mouradian, and a pan-European team, eureKARE has a rapidly growing portfolio of companies that have the potential to disrupt the life sciences industry.
For more information
Marina Shapochnik, Head of Investor Relations
Consilium Strategic Communications
Amber Fennell, Sukaina Virji, Genevieve Wilson
+44 (0) 203 709 5000